PGD Arizona | Gender Screening Arizona
Search

Preimplantation Genetic Diagnosis

Up to 70% of all embryos created do not survive the first three months of pregnancy, and many don’t achieve implantation because of a specific known genetic condition or chromosome abnormality.

For over a decade our national Boston IVF network of laboratories has performed groundbreaking genetic techniques that allow us to identify which embryos are most likely to result in a healthy pregnancy. Through tests like Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD), our team of scientists and embryologists analyze the genetic makeup of each embryo to eliminate abnormalities and gene disorders.

These crucial genetic tests improve IVF success rates and help to ensure you give birth to a healthy baby.

PREIMPLANTATION GENETIC SCREENING (PGS)

Preimplantation Genetic Screening (PGS) screens an embryo for chromosomal abnormalities prior to implantation and determines whether or not it has the correct number of chromosomes.

PGS is crucial to the success of IVF, as chromosomal errors (aneuploidy) in embryos lead to their failure to implant and cause most miscarriages.

CaptureThis test increases pregnancy success rates and is a valuable option for women of advanced age, as well as women who have experienced recurrent miscarriage or multiple unsuccessful IVF cycles.

WHO DOES PGS HELP?

We suggest PGS for the following patient populations:

  • individuals or couples over 35 years old
  • individuals or couples who have experienced several unsuccessful IVF cycles
  • individuals and couples whose prior IVF failures are unexplained
  • individuals or couples who have experienced multiple miscarriages

WHAT ARE THE BENEFITS OF PGS?

  • PGS increases your fertility success rates
  • PGS increases your chance of a genetically normal embryo being selected
  • PGS increases your chance of an embryo implanting successfully
  • PGS reduces the need for multiple IVF cycles
  • PGS reduces the likelihood of having a miscarriage
  • PGS test results are ready in just 2-3 weeks

geneticsDOES PGS HELP WOMEN OF ADVANCED AGE?

Absolutely. PGS screens an embryo for abnormalities, increases pregnancy rates and reduces miscarriage rates.

As a woman ages, her risk of chromosome and genetic abnormalities increases. This causes a lower chance of pregnancy and a higher chance of miscarriage. Abnormal embryos that create a pregnancy may result in a miscarriage or a baby with a chromosome disorder such as trisomy 21, or Down Syndrome.

If you are close to or over the age of 40, or have had recurrent miscarriages, been through several unsuccessful IVF cycles, this extremely accurate test can help determine if your embryo is healthy before implantation.

OUR PGS-WITH-IVF TREATMENT PLAN

  • $10,500 all-inclusive cycle
  • Includes all visits
  • PGS reduces the need for multiple IVF cycles
  • PGS reduces the likelihood of having a miscarriage

Contact our team to learn more about our IVF w/PGS Program.

 

PREIMPLANTATION GENETIC DIAGNOSIS (PGD)

Preimplantation Genetic Diagnosis (PGD) is a genetic test, done in conjunction with IVF, which analyzes an embryos for a specific genetic disease. By removing just one cell from an embryo, our genetic technologies have the ability to successfully detect any genetic mutations.

It improves the likelihood of a successful pregnancy and birth for individuals and couples who are at risk for passing on an inherited genetic disease to their children.

WHAT ARE THE BENEFITS OF PGD?

  • screens your embryos for over 400 hereditary diseases before they are transferred back into the uterus
  • reduces the chance of conceiving a child with a genetic factor
  • increases your chance of carrying and delivering a healthy baby

WHO DOES PGD HELP?

We suggest PGS for the following patient populations:

  • individuals or couples who have experienced several unexplained or unsuccessful IVF cycles
  • individuals or couples over 35 years old
  • individuals or couples who have experienced multiple miscarriages
  • individuals or couples who are carriers of a chromosomal abnormality
  • individuals or couples with a family history of Cystic Fibrosis, Fragile-X syndrome, Spinal Muscular Atrophy or Huntington’s disease

capture